These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23778476)

  • 1. Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components.
    Cunha PA; Shinzato FA; Tecchio GT; Weber SL; Brasil A; Avakian A
    Clinics (Sao Paulo); 2013 Jun; 68(6):834-9. PubMed ID: 23778476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle.
    Lorenz K; Dick B; Jehkul A; Auffahrt GU
    Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1617-22. PubMed ID: 18726610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK.
    Campos M; Muccioli C; Malta JB; Gerade RA; LA Salame A; Belfort R
    Clin Ophthalmol; 2011; 5():209-14. PubMed ID: 21386913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery.
    Demco TA; Sutton H; Demco CJ; Raj PS
    Eur J Ophthalmol; 1997; 7(3):236-40. PubMed ID: 9352276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery.
    Kavuncu S; Horoz H; Ardagil A; Erbil HH
    Int Ophthalmol; 2008 Aug; 28(4):281-5. PubMed ID: 17762913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
    Donnenfeld ED; Holland EJ; Solomon KD; Fiore J; Gobbo A; Prince J; Sandoval HP; Shull ER; Perry HD
    Am J Ophthalmol; 2011 Oct; 152(4):609-617.e1. PubMed ID: 21704965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
    Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA;
    Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification.
    Trinavarat A; Atchaneeyasakul LO; Surachatkumtonekul T; Kosrirukvongs P
    J Med Assoc Thai; 2003 Feb; 86(2):143-50. PubMed ID: 12678152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracameral moxifloxacin after cataract surgery: a prospective study.
    Lucena NP; Pereira IMS; Gaete MIL; Ferreira KSA; Mélega MV; Lira RPC
    Arq Bras Oftalmol; 2018 Apr; 81(2):92-94. PubMed ID: 29846429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery.
    Yaylali V; Ozbay D; Tatlipinar S; Yildirim C; Ozden S
    Int Ophthalmol; 2004 Jan; 25(1):65-8. PubMed ID: 15085979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.
    Donnenfeld ED; Solomon KD; Matossian C
    J Cataract Refract Surg; 2018 Oct; 44(10):1236-1246. PubMed ID: 30139638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
    El Gharbawy SA; Darwish EA; Abu Eleinen KG; Osman MH
    Eur J Ophthalmol; 2019 Jul; 29(4):453-457. PubMed ID: 30203671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification.
    Karalezli A; Borazan M; Akova YA
    Acta Ophthalmol; 2008 Mar; 86(2):183-7. PubMed ID: 18162061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.
    Freitas LL; Soriano E; Muccioli C; Höfling-Lima AL; Belfort R
    Curr Med Res Opin; 2007 Dec; 23(12):3123-30. PubMed ID: 17980093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.
    Zhou AX; Messenger WB; Sargent S; Ambati BK
    Int Ophthalmol; 2016 Aug; 36(4):493-8. PubMed ID: 26577588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracapsular dexamethasone implant in patients undergoing phacoemulsification and intraocular lens implantation.
    Vianna LM; Freitas LL; Nosé W; Kanecadan LA; Soriano ES; Muccioli C; Belfort R
    Arq Bras Oftalmol; 2013; 76(4):226-8. PubMed ID: 24061833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV; Westfield KC; Chalkley TH
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.